RxNorm Semantic Concepts Index - 623
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "623".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 623 | Ambenonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 623 | Ambenonium | Designated preferred name (PT) | NO | |
| RxCUI: 623 | Ambenonium | Full form of descriptor (FN) | NO | |
| RxCUI: 623 | Ambenonium | Designated preferred name (PT) | NO | |
| RxCUI: 623 | Ambenonium | Full form of descriptor (FN) | NO | |
| RxCUI: 623033 | lubiprostone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 623033 | lubiprostone | Designated preferred name (PT) | YES | |
| RxCUI: 623033 | lubiprostone | Full form of descriptor (FN) | YES | |
| RxCUI: 623033 | lubiprostone | Designated preferred name (PT) | YES | |
| RxCUI: 623033 | lubiprostone | Full form of descriptor (FN) | YES | |
| RxCUI: 6232 | Propiomazine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 6232 | Propiomazine hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 6232 | Propiomazine hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 623400 | lacosamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 623400 | lacosamide | Designated preferred name (PT) | YES | |
| RxCUI: 623400 | lacosamide | Full form of descriptor (FN) | YES | |
| RxCUI: 623400 | lacosamide | Designated preferred name (PT) | YES | |
| RxCUI: 623400 | lacosamide | Full form of descriptor (FN) | YES | |
| RxCUI: 62342 | Substance with dopamine receptor agonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 62342 | Substance with dopamine receptor agonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 62342 | Substance with dopamine receptor agonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 62342 | Substance with dopamine receptor agonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 62342 | Substance with dopamine receptor agonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 62349 | ethacrynate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 62355 | Fibrinopeptide | Designated preferred name (PT) | NO | |
| RxCUI: 62355 | Fibrinopeptide | Full form of descriptor (FN) | NO | |
| RxCUI: 62356 | folate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 623671 | penicillin G benzathine 150000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 623672 | penicillin G procaine 150000 MEQ/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 623673 | penicillin G benzathine 150000 UNT/ML / penicillin G procaine 150000 MEQ/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 623675 | penicillin G Injectable Suspension [Bicillin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 623676 | penicillin G benzathine 150000 UNT/ML / penicillin G procaine 150000 MEQ/ML Injectable Suspension [Bicillin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 623677 | penicillin G benzathine 300000 UNT/ML / penicillin G procaine 300000 UNT/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 623694 | penicillin G procaine 150000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 623695 | Benzathine benzylpenicillin 150000 unit/mL and procaine benzylpenicillin 150000 unit/mL suspension for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 623695 | Benzathine benzylpenicillin 150000 unit/mL and procaine benzylpenicillin 150000 unit/mL suspension for injection | Designated preferred name (PT) | NO | |
| RxCUI: 623695 | Benzathine benzylpenicillin 150000 unit/mL and procaine benzylpenicillin 150000 unit/mL suspension for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 623695 | Benzathine benzylpenicillin 150000 unit/mL and procaine benzylpenicillin 150000 unit/mL suspension for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 62372 | hyaluronate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |